Camlin Fine Sciences Balance Sheet Health
Financial Health criteria checks 3/6
Camlin Fine Sciences has a total shareholder equity of ₹6.7B and total debt of ₹7.4B, which brings its debt-to-equity ratio to 111.2%. Its total assets and total liabilities are ₹18.9B and ₹12.2B respectively. Camlin Fine Sciences's EBIT is ₹273.8M making its interest coverage ratio 0.4. It has cash and short-term investments of ₹905.9M.
Key information
111.2%
Debt to equity ratio
₹7.39b
Debt
Interest coverage ratio | 0.4x |
Cash | ₹905.90m |
Equity | ₹6.65b |
Total liabilities | ₹12.20b |
Total assets | ₹18.85b |
Recent financial health updates
Camlin Fine Sciences (NSE:CAMLINFINE) Has A Somewhat Strained Balance Sheet
Mar 29Camlin Fine Sciences (NSE:CAMLINFINE) Takes On Some Risk With Its Use Of Debt
Feb 26Camlin Fine Sciences (NSE:CAMLINFINE) Takes On Some Risk With Its Use Of Debt
Nov 21Recent updates
A Piece Of The Puzzle Missing From Camlin Fine Sciences Limited's (NSE:CAMLINFINE) 26% Share Price Climb
Nov 27Camlin Fine Sciences (NSE:CAMLINFINE) Will Be Hoping To Turn Its Returns On Capital Around
Oct 19Camlin Fine Sciences (NSE:CAMLINFINE) Has A Somewhat Strained Balance Sheet
Mar 29Positive Sentiment Still Eludes Camlin Fine Sciences Limited (NSE:CAMLINFINE) Following 26% Share Price Slump
Mar 29Is There An Opportunity With Camlin Fine Sciences Limited's (NSE:CAMLINFINE) 31% Undervaluation?
Sep 02Is It Time To Consider Buying Camlin Fine Sciences Limited (NSE:CAMLINFINE)?
Apr 06Rainbows and Unicorns: Camlin Fine Sciences Limited (NSE:CAMLINFINE) Analysts Just Became A Lot More Optimistic
Feb 19Camlin Fine Sciences Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Nov 17Should You Think About Buying Camlin Fine Sciences Limited (NSE:CAMLINFINE) Now?
Oct 15Camlin Fine Sciences Limited (NSE:CAMLINFINE) Shares Could Be 32% Below Their Intrinsic Value Estimate
Jan 15Returns On Capital At Camlin Fine Sciences (NSE:CAMLINFINE) Paint A Concerning Picture
Jan 04Why Camlin Fine Sciences Limited (NSE:CAMLINFINE) Could Be Worth Watching
Nov 30Investors Could Be Concerned With Camlin Fine Sciences' (NSE:CAMLINFINE) Returns On Capital
Oct 05At ₹163, Is Camlin Fine Sciences Limited (NSE:CAMLINFINE) Worth Looking At Closely?
Aug 20Estimating The Intrinsic Value Of Camlin Fine Sciences Limited (NSE:CAMLINFINE)
Jun 30Camlin Fine Sciences (NSE:CAMLINFINE) Takes On Some Risk With Its Use Of Debt
Feb 26What Is Camlin Fine Sciences Limited's (NSE:CAMLINFINE) Share Price Doing?
Feb 15Is Camlin Fine Sciences Limited (NSE:CAMLINFINE) Popular Amongst Insiders?
Feb 05Camlin Fine Sciences (NSE:CAMLINFINE) Shareholders Booked A 29% Gain In The Last Year
Jan 26Here's What To Make Of Camlin Fine Sciences' (NSE:CAMLINFINE) Returns On Capital
Jan 16Don't Ignore The Fact That This Insider Just Sold Some Shares In Camlin Fine Sciences Limited (NSE:CAMLINFINE)
Jan 06Should You Be Adding Camlin Fine Sciences (NSE:CAMLINFINE) To Your Watchlist Today?
Jan 04Can Mixed Fundamentals Have A Negative Impact on Camlin Fine Sciences Limited (NSE:CAMLINFINE) Current Share Price Momentum?
Dec 24How Should Investors React To Camlin Fine Sciences' (NSE:CAMLINFINE) CEO Pay?
Dec 13Does Camlin Fine Sciences's (NSE:CAMLINFINE) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 02Camlin Fine Sciences (NSE:CAMLINFINE) Takes On Some Risk With Its Use Of Debt
Nov 21Is Now An Opportune Moment To Examine Camlin Fine Sciences Limited (NSE:CAMLINFINE)?
Nov 09The Camlin Fine Sciences (NSE:CAMLINFINE) Share Price Is Up 49% And Shareholders Are Holding On
Oct 27What Do The Returns On Capital At Camlin Fine Sciences (NSE:CAMLINFINE) Tell Us?
Oct 14Camlin Fine Sciences Limited's (NSE:CAMLINFINE) 29% Price Boost Is Out Of Tune With Earnings
Oct 01Here's Why I Think Camlin Fine Sciences (NSE:CAMLINFINE) Might Deserve Your Attention Today
Sep 30What Kind Of Shareholders Hold The Majority In Camlin Fine Sciences Limited's (NSE:CAMLINFINE) Shares?
Sep 17Read This Before Judging Camlin Fine Sciences Limited's (NSE:CAMLINFINE) ROE
Sep 04Financial Position Analysis
Short Term Liabilities: CAMLINFINE's short term assets (₹10.2B) exceed its short term liabilities (₹8.5B).
Long Term Liabilities: CAMLINFINE's short term assets (₹10.2B) exceed its long term liabilities (₹3.7B).
Debt to Equity History and Analysis
Debt Level: CAMLINFINE's net debt to equity ratio (97.5%) is considered high.
Reducing Debt: CAMLINFINE's debt to equity ratio has increased from 102.4% to 111.2% over the past 5 years.
Debt Coverage: CAMLINFINE's debt is well covered by operating cash flow (21.8%).
Interest Coverage: CAMLINFINE's interest payments on its debt are not well covered by EBIT (0.4x coverage).